Disseminated Nocardia farcinica: Literature Review and Fatal Outcome in an Immunocompetent Patient

Department of Pathology, Pritzker School of Medicine, Chicago, Illinois, USA.
Surgical Infections (Impact Factor: 1.72). 05/2012; 13(3):163-70. DOI: 10.1089/sur.2011.012
Source: PubMed

ABSTRACT Nocardia farcinica is a gram-positive, partially acid-fast, methenamine silver-positive aerobic actinomycete. Nocardia spp. are opportunistic pathogens, and N. farcinica is the least common species of clinical importance.
Review of the recent literature and description of a immunocompetent patient with no known risk factors who contracted fatal N. farcinica sepsis.
Positive pre-mortem and post-mortem cultures from the lung and synovium correlated with acute bronchopneumonia and synovitis at autopsy. Colonies of filamentous bacteria, which were not apparent in conventional hematoxylin and eosin-stained sections, were observed with gram and methenamine silver stains, but acid-fast stains were negative. A literature review revealed that disseminated N. farcinica often is associated with an underlying malignant tumor or autoimmune disease (88% of patients). Chemotherapy or corticosteroid treatments are additional risk factors.
Trimethoprim-sulfamethoxazole typically is the first-line therapy for N. farcinica; treatment with amikacin and imipenem-cilastatin is used less often (7% of patients). Despite aggressive therapy, we observed that the death rate (39%) associated with N. farcinica in recent publications was eight percentage points higher than reported in a review from 2000.

Download full-text


Available from: Alexander Craig Mackinnon, Jun 29, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nocardia spp. has not been reported previously as a cause of post-influenza pneumonia. Here we present a first case of post-influenza bacterial pneumonia due to Nocardia farcinica. Initial reason for hospitalization of the 90 year old female patient was a pneumonia with the symptoms of fever and productive cough. A rapid test for influenza antigen was positive for influenza A virus. Treatment with Zanamivir and piperacillin was initiated. However, after 1 week of treatment, the infiltration shadows on chest X-ray had worsened. Because the expectorated sputum collected on admission for culture was found to be positive for Nocardia spp., piperacillin was replaced with trimethoprim/sulfamethoxazole, and a chest X-ray showed some improvement. Although pulmonary nocardiosis with co-infection with influenza A is extremely rare, clinicians should be alert to the possibility.
    Journal of Infection and Chemotherapy 05/2014; 20(7-8). DOI:10.1016/j.jiac.2014.04.008 · 1.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: : Anti-tumor necrosis factor (anti-TNF) therapy is beneficial in the management of many chronic immune-mediated inflammatory diseases. However, its use is associated with increased risk of bacterial, fungal and viral infections. We present a case of cutaneous nocardiosis that occurred in a 61-year-old man, whose Crohn's disease was treated for nearly 1.5 years with infliximab. Prompt therapy with trimethoprim-sulfamethoxazole led to complete resolution. Only few cases of nocardiosis complicating anti-TNF therapy are reported in the literature. We present the case report and summary of the available literature with updates on the management and the treatment of the disease.
    The American Journal of the Medical Sciences 03/2013; DOI:10.1097/MAJ.0b013e3182883708 · 1.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Critical Care Case Report Posters IISESSION TYPE: Affiliate Case Report PosterPRESENTED ON: Tuesday, October 29, 2013 at 01:30 PM - 02:30 PMINTRODUCTION: Infectious complications in immunocompromised patients carry high mortality and are often difficult to identify and treat. We report a case of Nocardia farcinica bacteremia in a patient receiving chemotherapy for multiple myeloma.CASE PRESENTATION: A 71 year old female with h/o Multiple Myeloma on chemotherapy with bortezomib and dexamethasone was admitted with fever, chills, cough and progressive lethargy. On admission, she was febrile, tachycardic, and tachypneic. Lung exam revealed left sided rales. Laboratory examination was significant for leukocytosis of 21,000 per microliter. Chest x-ray revealed a left upper lobe opacity. She was treated with broad spectrum antibiotics after blood cultures were drawn. Her condition then worsened and she developed acute respiratory distress sydrome (ARDS) on day 2 requiring intubation and mechanical ventilation and multiple vasopressors. On day 4, blood cultures drawn on admission grew Nocardia species and she was started on trimethoprim-sulfamethoxazole (TMP-SMZ), Imipenem and Amikacin. In spite of aggressive management, she expired from multi-organ failure. Nocardia was subsequently identified as N. farcinica.DISCUSSION: Nocardia is an aerobic gram positive, partially acid-fast bacterium found ubiquitously in soil and water(1) and its isolation from blood is rare(2). There are about 50 different species of Nocardia identified, of these N. farcinica constitute 19%(3). N. farcinica is characterized by its high resistance to conventional antibiotics and propensity to cause disseminated infection. It is associated with high mortality ranging from 31% to 39%(2). In a recent review, out of 67 cases of Nocardia farcinica from 2000 to 2012, 88% were in immunocompromised patients. Most common risk factors include immunosuppression with steroids or chemotherapy (61%), solid organ transplant (12%), COPD (9%) and malignancy (8%)(2). N. farcinica isolates are resistant to ampicillin, cefixime, tobramycin, and third generation cephalosporins. They are usually susceptible to Amikacin, Dapsone and TMP-SMZ(1,3). The treatment of choice for Nocardia is TMP-SMX. Other antibiotics like Imipenem, Amikacin and Linezolid have also been tried.CONCLUSIONS: Nocardia should be considered in the differential diagnosis in a patient with immunocompromised conditions especially those being treated with steroids and chemotherapy and in transplant recipients. Since isolation of Nocardia is difficult, empiric treatment against it should be considered if there is no response to conventional empiric broad spectrum regimens.Reference #1: Lerner PI. Nocardiosis. Clinical Infect Dis 1996; 22:891-903Reference #2: Budzik JM et al. Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient. Surg Infect. 2012 Jun;13(3):163-70Reference #3: Wallace RJ Jr, Tsukamura M, Brown BA, et al. Cefotaxime resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol 1990; 28:2726-2732DISCLOSURE: The following authors have nothing to disclose: Praveen Bondalapati, Ruchi Bansal, Pramil Vaghasia, Liziamma GeorgeNo Product/Research Disclosure Information.
    Chest 10/2013; 144(4_MeetingAbstracts):281A. DOI:10.1378/chest.1705187 · 7.13 Impact Factor